Top Markets
Coin of the day
Neuca S.a. Neuca S.a.

Neuca S.a.

NEU
Clasificación en acciones #9484
NEUCA S.A., headquartered in Torun, Poland, specializes in supplying... NEUCA S.A., headquartered in Torun, Poland, specializes in supplying pharmaceutical products to pharmacies and healthcare facilities throughout the country. The firm structures its business around distinct segments: wholesale pharmaceutical distribution, the development and marketing of proprietary drug brands, and a comprehensive healthcare services division. This healthcare arm specifically encompasses outpatient care, clinical trials, and telemedicine. Beyond these core areas, NEUCA S.A. provides an extensive array of additional services, including marketing and advertising support, agency functions, financial solutions, logistics through road cargo transport, accounting and bookkeeping, software development, information technology support, and specialized services for hospitals. The company also offers various insurance products—covering health, property, and other personal lines—and operates its own network of medical supply stores. Established in 1990 as Torfarm SA, the company rebranded to NEUCA S.A. in April 2010.
Precio por acción
$222.12
Última sincronización: 2026-08-28
Capitalización bursátil
$1.00B
Cambio (1 día)
-0.75%
Cambio (1 año)
24.88%
País
PL
Comercio Neuca S.a. (NEU)

Categoría

Ingresos de Neuca S.a. (NEU)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Neuca S.a., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Neuca S.a. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$410.98B -
US
- -
US
$254.25B -
US
- -
US
$7.64B -
AU